Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc. is strategically positioned in the biotechnology sector with its Enhanced Delivery Oligonucleotide platform, which has demonstrated superior efficacy in delivering therapeutic oligonucleotides, reflected in the significant 53.7% splicing correction achieved in its pipeline product, PGN-EDO51. With its shares currently trading around $4 per share and the anticipated release of favorable multi-dose data, there is potential for substantial upside. The strong preclinical performance of PepGen’s therapies, combined with anticipated regulatory progress, supports a positive outlook for the company amid increasing investor interest in innovative biotechnology solutions.

Bears say

The analysis of PepGen Inc. indicates a negative outlook primarily due to a recent decrease in the target valuation to $8 per share, which highlights a lack of confidence in future growth despite promising preclinical results. The company's discounted market capitalization raises concerns about its competitive position, especially in light of competitors like Dyne Therapeutics that have established regulatory momentum, making PepGen's valuation appear anomalous. Additionally, potential difficulties in accessing capital markets could impede development programs, further exacerbating the risk of failing to meet commercial expectations and adversely affecting stock performance.

PepGen Inc (PEPG) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 4 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Jan 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.